Norwood Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$4.9K Sell
261
-108
-29% -$1.85K 0.01% 260
2023
Q4
$5.32K Sell
369
-25
-6% -$340 0.01% 245
2023
Q3
$6.83K Sell
394
-10
-2% -$209 0.01% 237
2023
Q2
$8.4K Hold
404
0.01% 233
2023
Q1
$9.5K Hold
404
0.02% 221
2022
Q4
$11.3K Sell
404
-10
-2% -$256 0.02% 215
2022
Q3
$10K Hold
414
0.02% 213
2022
Q2
$14K Hold
414
0.02% 195
2022
Q1
$14K Hold
414
0.02% 197
2021
Q4
$12K Buy
+414
New +$13.5K 0.02% 211

Other funds holding OGN

Norwood Financial's OGN Position: Q1 2024 in Review

Norwood Financial reduced its Organon & Co (OGN) stake by 29% in Q1 2024, selling an estimated $1.85K and leaving 261 shares worth $4.9K. The position accounts for 0.01% of the portfolio, ranked #260.

Norwood Financial first reported a position in OGN in Q4 2021 and has held it in 10 quarters since. The position peaked at $14K in Q2 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Norwood Financial held 261 shares of Organon & Co worth $4.9K as of Q1 2024.
  • Norwood Financial sold 108 Organon & Co shares in Q1 2024, an estimated $1.85K.
  • Organon & Co made up 0.01% of Norwood Financial's portfolio in Q1 2024, its #260 holding.
  • Norwood Financial first reported a position in Organon & Co in Q4 2021 and has held it in 10 quarters since.
  • Norwood Financial's Organon & Co position peaked at $14K in Q2 2022.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.